|
Akselrod, S., Gordon, D., Ubel, F. A., Shannon, D. C., Berger, A. C. and Cohen, R. J., 1981. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 213, 220-222. Allebeck, P., 1989. Schizophrenia: a life-shortening disease. Schizophr Bull. 15, 81-89. Bar, K. J., Letzsch, A., Jochum, T., Wagner, G., Greiner, W. and Sauer, H., 2005. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res. 39, 519-527. Barutcu, I., Esen, A. M., Kaya, D., Turkmen, M., Karakaya, O., Melek, M., Esen, O. B. and Basaran, Y., 2005. Cigarette smoking and heart rate variability: dynamic influence of parasympathetic and sympathetic maneuvers. Ann Noninvasive Electrocardiol. 10, 324-329. Bayer, R. and Stuber, J., 2006. Tobacco control, stigma, and public health: rethinking the relations. Am J Public Health. 96, 47-50. Binkley, P. F., Nunziata, E., Haas, G. J., Nelson, S. D. and Cody, R. J., 1991. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol. 18, 464-472. Bromet, E. J. and Fennig, S., 1999. Epidemiology and natural history of schizophrenia. Biol Psychiatry. 46, 871-881. Chute, D., Grove, C., Rajasekhara, B. and Smialek, J. E., 1999. Schizophrenia and sudden death: a medical examiner case study. Am J Forensic Med Pathol. 20, 131-135. Collishaw, N. E., 2004. Global tobacco control must become a top public health priority. Int J Tuberc Lung Dis. 8, p1159. Davidson, M., 2002. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry. 63 Suppl 9, 5-11. De Hert, M., van Winkel, R., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A. and Peuskens, J., 2006. Prevalence of the diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemol Ment Health. 2, 14. 36 Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A. and Lehman, A., 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 26, 903-912. Eryonucu, B., Bilge, M., Guler, N., Uzun, K. and Gencer, M., 2000. Effects of cigarette smoking on the circadian rhythm of heart rate variability. Acta Cardiol. 55, 301-305. Ewing, D. J., Martyn, C. N., Young, R. J. and Clarke, B. F., 1985. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 8, 491-498. Goff, D. C., Cather, C., Evins, A. E., Henderson, D. C., Freudenreich, O., Copeland, P. M., Bierer, M., Duckworth, K. and Sacks, F. M., 2005. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 66, 183-194 Hautecouverture, S., Limosin, F. and Rouillon, F., 2006. [Epidemiology of schizophrenic disorders]. Presse Med. 35, 461-468. Hayano, J., Yamada, M., Sakakibara, Y., Fujinami, T., Yokoyama, K., Watanabe, Y. and Takata, K., 1990. Short- and long-term effects of cigarette smoking on heart rate variability. Am J Cardiol. 65, 84-88. Holt, R. I., Peveler, R. C. and Byrne, C. D., 2004. Schizophrenia, the metabolic syndrome and diabetes. Diabet Med. 21, 515-523. Hon, E. H. and Lee, S. T., 1963. Electronic Evaluation Of The Fetal Heart Rate. Viii. Patterns Preceding Fetal Death, Further Observations. Am J Obstet Gynecol. 87, 814-826. Jablensky, A., 2000. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci. 250, 274-285. Kuo, T. B. J., Lin, T., Yang, C. C. H., Li, C. L., Chen, C. F. and Chou, P., 1999. Effect of aging on gender differences in neural control of heart rate. Am J Physiol. 277, H2233-H2239. Kuo, T. B. J., Yang, C. C. H., 2004. Scatterplot analysis of EEG slow-wave magnitude and heart rate variability: an integrative exploration of cerebral cortical and autonomic functions. Sleep. 15;27(4), 648-656. Lambert, T. J., Velakoulis, D. and Pantelis, C., 2003. Medical comorbidity in schizophrenia. Med J Aust. 178 Suppl, S67-70. 37 Langewitz, W., Ruddel, H. and Schachinger, H., 1994. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am Heart J. 127, 122-128. Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., Stroup, S., Weissman, E. M., Wirshing, D. A., Hall, C. S., Pogach, L., Pi-Sunyer, X., Bigger, J. T., Jr., Friedman, A., Kleinberg, D., Yevich, S. J., Davis, B. and Shon, S., 2004. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 161, 1334-1349. McDonald, C., 2000. Cigarette smoking in patients with schizophrenia. Br J Psychiatry. 176, 596-597. MMWR. 2005. Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. Morb Mortal Wkly Rep. 54, 625-628. Myers, G. A., Martin, G. J., Magid, N. M., Barnett, P. S., Schaad, J. W., Weiss, J. S., Lesch, M. and Singer, D. H., 1986. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng. 33, 1149-1156. Newman, S. C. and Bland, R. C., 1991. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry. 36, 239-245. Osby, U., Correia, N., Brandt, L., Ekbom, A. and Sparen, P., 2000. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 45, 21-28. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L. and Goodwin, F. K., 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama. 264, 2511-2518. Rossler, W., Salize, H. J., van Os, J. and Riecher-Rossler, A., 2005. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 15, 399-409. Sayers, B. M., 1973. Analysis of heart rate variability. Ergonomics. 16, 17-32. Singh, J. P., Larson, M. G., Tsuji, H., Evans, J. C., O'Donnell, C. J. and 38 Levy, D., 1998. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension. 32, 293-297. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 93, 1043-1065. WHO. 2004. WHO tobacco treaty set to become law, making global public health history. Indian J Med Sci. 58, 546-547. Wilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H. and Kannel, W. B., 1998. Prediction of coronary heart disease using risk factor categories. Circulation. 97, 1837-1847. Wolf, M. M., Varigos, G. A., Hunt, D. and Sloman, J. G., 1978. Sinus arrhythmia in acute myocardial infarction. Med J Aust. 2, 52-53. Yang, M. C., Fann, C. Y., Wen, C. P. and Cheng, T. Y., 2005. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tob Control. 14 Suppl 1, 62-70. Yotsukura, M., Koide, Y., Fujii, K., Tomono, Y., Katayama, A., Ando, H., Suzuki, J. and Ishikawa, K., 1998. Heart rate variability during the first month of smoking cessation. Am Heart J. 135, 1004-1009.
|